Quantum Biopharma Ltd. Files May 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 5, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, regulatory-filing
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its May 6-K, confirming 20-F annual report filings.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on May 5, 2025, reporting as a foreign private issuer. The company, formerly known as FSD Pharma Inc. until March 27, 2019, is incorporated in A6 and has its principal executive offices in Toronto, Canada. This filing is for the month of May 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's status as a foreign private issuer and its reporting practices.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- May 5, 2025 (date) — Filing date
- Toronto, Ontario (location) — Principal executive office location
- Form 20-F (document) — Annual report filing type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.
What was Quantum Biopharma Ltd. previously known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
The principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
The registrant indicates by check mark that it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding Quantum Biopharma Ltd. (QNTM).